We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eagle Follows Through on Threatened FDA Suit Over Exclusivity
Eagle Follows Through on Threatened FDA Suit Over Exclusivity
Eagle Pharmaceuticals has made good on a threat to sue the FDA over its refusal to grant the company full exclusivity rights for its cancer drug Bendeka.